Medmen Enterprises Inc
Curaleaf Holdings Completes Curaleaf NJ’s Acquisition
Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.
Green Thumb Keeps Expanding Its Operations in Las Vegas
On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.
Cannabis Market in Illinois Grows, Challenges Remain
The growth in Illinois’s cannabis market is evident from its record sales in May. The state sold adult-use cannabis worth $44.3 million in May.
MedMen’s Medical Marijuana Dispensary License Revoked in Virginia
The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.
Curaleaf Expands Select Brand Medical Products in Connecticut
On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.
IIPR Acquires Another Property in Pennsylvania
Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.
Illinois Reports Record Recreational Cannabis Sales in May
Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.
Green Thumb Industries Opens Its 46th Retail Store
On Monday, Green Thumb Industries (OTCMKTS:GTBIF) opened a Rise brand store in Chambersburg, Pennsylvania—its 46th store in the US.
Vireo Health Terminates Bruce Linton as Its Executive Chairman
On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.
Cannabis Market Has Good Potential in Illinois
The cannabis market in Illinois has been growing despite the COVID-19 pandemic. Illinois legalized recreational cannabis on January 1, 2020.
Cresco Labs: Analysts Revise 2020 Estimates after Earnings
Cresco Labs (OTCMKTS:CRLBF) is one of the US cannabis companies that has been consistently performing well despite the marijuana industry’s struggles.
MedMen Temporarily Closes Stores amid Protests
Amid the protests following George Floyd’s death in the US, MedMen temporarily closed all of its stores. The stock fell after the news.
Marijuana Legalization Might Bring Economic Relief in New Mexico
Governor Grisham thinks that marijuana is a good option to help New Mexico recover from the economic losses amid COVID-19.
Will Marijuana Stocks Continue to Surge in June?
May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.
Cresco Labs’ Q1 Earnings: Dazzling Growth amid COVID-19
Cresco Labs reported its results for the first quarter of fiscal 2020 on May 28. The stock declined 4.2% and closed at $4.8 on the OTC markets yesterday.
Why Green Thumb Industries Is a Good Cannabis Bet
So far in 2020, Green Thumb Industries has returned 6.0%—one of the few cannabis companies with positive returns this year.
Did MedMen’s Q3 Earnings Start a Path to Recovery?
MedMen released its results for the third quarter of fiscal 2020 on May 27. The stock declined 4.0% and closed at $0.35 on the OTC markets.
Will MedMen’s Q3 2020 Earnings Be a Relief?
MedMen Enterprises (OTCMKTS:MMNFF) is scheduled to report its financial results for the third quarter of fiscal 2020 on May 27 after the market closes.
Why Did Curaleaf Report a Mixed Q1 Performance?
On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.
Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings
Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.
Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings
Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.
IIPR Stock Falls after Reporting Weak Q1 Performance
On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.
Should You Buy IIPR before Its Q1 Earnings?
IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?
Is There More Upside to Cresco Labs’ Stock Price?
Amid the weakness in the global financial markets due to the COVID-19 outbreak, Cresco Labs fell to a low of 2.81 Canadian dollars on March 17.
Analysts Cut Curaleaf’s Target Price after Its Q4 Earnings
Since Curaleaf reported its fourth-quarter earnings on March 24, Alliance Global Partners and Canaccord Genuity have lowered their target prices.
Curaleaf Reports Impressive Q4 Earnings Results
On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.
Will Curaleaf Beat Analysts’ Expectations in Q4?
Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.
Marijuana Sales Soar amid Coronavirus Pandemic
Marijuana stocks are seeing a ray of hope amid the coronavirus pandemic. With self-quarantine and lockdowns in many cities, marijuana sales have risen.
Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings
As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”
Is the Coronavirus Impacting US Cannabis Sales?
The US cannabis industry has experienced lower sales amid the coronavirus chaos. The US stock market closed with a loss of 1.6% on March 6.
Charlotte’s Web Reports Improved Yield and CBD Potency
On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.
Tilray’s Q4 Earnings Force Analysts to Cut Its Target Price
Tilray (NASDAQ:TLRY) reported dismal results for the fourth quarter of fiscal 2019 on Tuesday. The losses widened in the fourth quarter.
Connecticut Will Hear Public’s View on Marijuana Legalization
Marijuana legalization is a hot top topic in the US as the presidential 2020 election gets closer. Legalization is a priority for Connecticut in 2020.
How Will Curaleaf Benefit from Acquiring BlueKudu?
On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.
Acreage Holdings’ Q4 Results Dragged Its Stock Down
Acreage Holdings stock fell after its fourth-quarter earnings results. The company reported its results on Tuesday after the market closed.
Analysts Cut GW Pharmaceuticals’s Target Price after Q4 Earnings
On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings. The company reported revenue of $109.1 million, which beat analysts’ expectations.
IIPR Posts Impressive Q4 Earnings, Looks Strong in 2020
On Wednesday, IIPR reported its fourth-quarter earnings. The company reported revenues of $17.7 million, which beat analysts’ expectations of $14.4 million.
Will Acreage Holdings’ Q4 Results Help Its Stock?
Acreage Holdings will report its fourth-quarter and fiscal 2019 results today after the market closes. Analysts expect the company to report revenue growth.
Green Growth Brands Reported Mixed Q2 Performance
On Monday, Green Growth Brands reported its earnings results for the second quarter of fiscal 2020. The company reported revenues of $21.1 million.
Elizabeth Warren Unveils Plan for Marijuana Legalization
According to Warren’s new marijuana plan, the federal legalization process would start within 100 days of her taking office.
Will MedMen Deliver Any Good News in Its Q2 Earnings?
MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.
Has Cresco Labs Bottomed Out in 2020?
As of Tuesday, Cresco Labs was trading at 6.73 Canadian dollars, which represents a fall of 24.6% since the beginning of the year.
Beacon Securities Is Still Bullish on Curaleaf
After Curaleaf completed the acquisition of the Select brand, Russell Stanley of Beacon Securities reiterated his “buy” rating.
Why Beacon Securities Is Bullish on Curaleaf
On Monday, Russell Stanley of Beacon Securities reiterated his “buy” rating for Curaleaf Holdings. He gave a target price of 25 Canadian dollars.
GW Pharmaceuticals Provides Preliminary Sales Update
On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.
‘Make It Legal Florida’ Cannabis Campaign’s Next Step
Florida’s “Make It Legal Florida” measure could push other states to look at cannabis legalization. However, President Trump doesn’t seem supportive.
Joe Biden Wants More Research on Vaping
Democratic nominee Joe Biden thinks e-cigarette sales should only be allowed after scientific analysis of the products’ long-term impact on health.
Why Beacon Securities Thinks Cresco Labs Is Cheap
Russell Stanley of Beacon Securities is optimistic about Cresco Labs (CRLBF) in the cannabis space. He maintained the “buy” rating and target price.
Why Origin House’s Acquisition Is Vital for Cresco Labs
On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.
Why MedMen Is Selling Its Assets
Facing a cash crunch, MedMen entered into a definitive agreement with Gotham Green Partners for a $250 million senior secured convertible credit facility.
What Analysts Think About Curaleaf in Fiscal 2020
Curaleaf (CURLF) seems to be in a good position in 2019 compared to other cannabis players. Can it keep up its performance in 2020?
Will Santa Claus Rally Boost Cannabis Stocks?
On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.
What’s Driving Cannabis Stocks Today?
Boosted by the strong performance from the broader equity market, the cannabis sector was trading in the green today.
Understanding MedMen’s Cannabis Logistics Software
Cannabis retailer MedMen Enterprises (MMNFF) has partnered with Onfleet software to handle its multistate logistics.
Cannabis Sector Rounds Out the Week in the Green
Yesterday, Ontario’s government announced that it was scrapping its cap on the number of private retail cannabis stores and moving toward a new system.
Why MedMen Stock Rose More than 24% on Thursday
The optimistic guidance and initiatives helped MedMen stock rise. On Thursday, the stock closed the day at 0.71 Canadian dollars.
Regulators Beware: Cannabis Linked to Job Loss
Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.
A Deep Dive into the Top Cannabis Retailers in Florida
Since Florida legalized medical marijuana, business is booming. In September, the state had 22 licensed vertically integrated medical cannabis operators.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
MedMen: Price Targets and Ratings after Q1 Earnings
There have been no rating changes since MedMen reported its Q1 earnings. Six of eight analysts gave the stock a “hold” rating.
Marijuana Legalization: Can Virginia Expect it in 2020?
Marijuana is strictly prohibited in Virginia. All forms of marijuana are illegal in the state. Yet, recreational sales went live in Michigan on Sunday.
Marijuana in Hawaii: Is Further Legalization Likely?
We’ve previously discussed the varying degrees of marijuana legalization in a variety of US states. Now, let’s talk about the laws in Hawaii.
How MedMen Is Staking Its Claim in Cannabis Retail
Major US cannabis retailer MedMen aims to expand its brand by increasing its number of flagship retail stores and offering high-quality cannabis products.
Analysts Believe the FDA Will Get Tough on CBD
Earlier this week, the FDA announced that it couldn’t conclude CBD was safe. It warned the public of various risks linked to CBD usage.
Key Takeaways from MedMen’s First-Quarter Earnings
Cannabis retailer MedMen (MMNFF)(MMEN) reported its first quarter of fiscal 2020 earnings results yesterday. Here’s what you need to know.
Cannabis Is Up Today: The Latest from CGC and Its Peers
The cannabis sector is in the green today. At 12:58 PM ET, the ETFMG Alternative Harvest ETF and Horizons Marijuana Life Sciences Index ETF were up 0.8%.
Acreage: Analysts Lower Targets after Q3 Earnings
Acreage Holdings (ACRG)(ACRGF) reported its third-quarter earnings after markets closed on November 12. Here’s how analysts have reacted since.
Can Cresco Lab’s Q3 Earnings Drive the Cannabis Sector?
As of November 22, Cresco Labs was trading at 7.65 Canadian dollars, which implies a fall of 30% since its second-quarter earnings on August 21.
Harvest Health: Price Targets, Ratings after Q3 Earnings
Harvest Health (HARV) reported its Q3 earnings yesterday. HARV posted revenue of $33.15 million, which was lower than analysts’ estimate of $34.18 million.
California Tightens Noose around Cannabis Industry
California’s legal cannabis market spending will rise from $3.1 billion in 2019 to $7.2 billion in 2024. The market could be $11.0 billion by 2030.
NHS Approves Cannabis Medicines: Market Impact
On November 11, the NHS (National Health Service) approved two cannabis-based medicines, Epidyolex and Sativex, for use in the United Kingdom.
MedMen Fights for Survival amid Sector Meltdown
On November 15, MedMen (MMEN) (MMNFF) declared an extensive five-year restructuring plan in its attempt to become EBITDA-positive by 2020.
Cannabis Stocks Continue to Tremble after Earnings
Last week, three prominent cannabis companies—Cronos Group (CRON), Aurora Cannabis (ACB), and Canopy Growth (CGC)(WEED)—reported earnings results.
Charlotte’s Web: Analysts Cut Targets after Weak Q3
Charlotte’s Web Holdings reported its fiscal 2019 third-quarter earnings results on November 13. Its revenue came in at $25.1 million.
Charlotte’s Web: Q3 Earnings Missed Analysts’ Estimates
Today, Charlotte’s Web Holdings (CWEB) (CWBHF) reported its third-quarter earnings. The company missed analysts’ revenue and EPS estimates.
Why Cannabis Stocks Are in the Red Today
The cannabis sector was trading in the red today. MKM Partners lowered its revenue estimates for Canopy Growth (CGC) (WEED) and Aurora Cannabis (ACB).
Charlotte’s Web: What to Expect from Q3 Earnings
Charlotte’s Web Holdings (CWEB) (CWBHF) will report third-quarter earnings before the market opens on November 13. Let’s look at analysts’ expectations.
MedMen: Analysts’ Views before Its Earnings
MedMen’s disappointing fourth-quarter results caused the stock price to fall. The company missed analysts’ revenue estimates for the quarter.
Curaleaf Launches Adult-Use Cannabis in MA
Yesterday, Curaleaf Holdings (CURLF) (CURA) opened its first recreational or adult-use dispensary in Massachusetts at Oxford.
Charlotte’s Web: Top Four Things to Know about the Stock
Last month, Charlotte’s Web announced that it would partner with Nielsen to guide US retail companies on the growth of the CBD (cannabidiol) space.
Cannabis Stocks in the Green alongside S&P 500
Investors’ optimism about a US–China trade deal helped the market trade in the green today—and cannabis stocks are also trending higher. Here’s why.
MedMen Buds: Loyalty Program Information
MedMen (MMNFF) is a vertically integrated cannabis retailer with its footprint across the US. The company is in nine states and has 32 stores and 70 retail licenses. Recently, the company launched a loyalty program called MedMen buds. Also, the company launched its omnichannel delivery services in August. What is MedMen Buds? MedMen Buds is […]
HEXO: Analysts Downgrade, But Stock Rises 1%
HEXO Corp. (HEXO) reported its Q4 earnings of fiscal 2019. The company posted revenues of $15.42 million Canadian dollars.
Marijuana in Florida: Five Things You Should Know
Florida is the second-fastest adopter of medical marijuana. The state reports an average increase of 609 medical marijuana patients on a daily basis.
MedMen: Stock Falls over 20% after Q4 2019 Earnings
MedMen Enterprises (MMEN) (MMNFF) reported its fourth-quarter earnings that ended on June 30. The company reported revenues of $41.97 million.
Marijuana: Why Did Mexico Delay Legalization?
Mexico has delayed marijuana legalization. The Supreme Court’s deadline for legalization was October 23. The delay could stretch into November.
Cannabis Roundup: HEXO, APHA, and MMEN
At 2:10 PM ET, the S&P 500 Index and the DJIA rose 0.6% and 0.5%, respectively. However, the cannabis sector is trading in the red today.
Marijuana in Texas: Five Things You Should Know
Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.
How Marijuana Legalization May Boost Florida’s Economy
Right now, medical marijuana is legal in 33 states. Florida is one state that may aggressively push for recreational marijuana legalization in 2020.
MedMen: Analysts’ Lower Target Price and Ratings
October has been tough for the cannabis sector. As of Monday, MedMen was trading at 1.58 Canadian dollars, which represents a fall of 18.6% this year.
Why Did MedMen and PharmaCann Call it Off?
On October 8, MedMen Enterprises (MMEN) (MMNFF) announced that it would not buy PharmaCann. Both parties decided to call off this all-stock transaction. MedMen valued PharmaCann at $682 million. The company planned to fund the deal through equity dilution. Once the deal was complete, PharmaCann shareholders would account for 25% ownership in the new combined […]
Cannabis Roundup: MMEN, APHA, ACB, and TGOD
The US markets rose on optimism surrounding US-China trade talks. However, weakness in the cannabis sector led the cannabis ETFs trading in the red.
Cannabis Roundup: HEXO, MMEN, WEED, and CRON
At 1:40 PM ET, the S&P 500 and the Dow Jones Industrial Average were up 0.2% and 0.3%, respectively. However, cannabis ETFs were trading in the red.
Cannabis Roundup: STZ, CURLF, MMNFF, and ACB
Today, the US markets were trading in the green on the expectation of rate cuts. The cannabis ETFs and the majority of cannabis stocks were also up today.
Will Cannabis Stocks Bleed More? MKM Weighs In
This year, the cannabis sector has been underperforming the broader equity market. Will cannabis stocks bleed more after MKM Partners’ bearish outlook?
MedMen: Analysts’ Target Price and Ratings
After MedMen reported its preliminary fourth-quarter earnings, Cormark Securities reduced the target price to 6.5 Canadian dollars from 7.5 Canadian dollars.
Cannabis Roundup: CURA, CL, CRON, and MMEN
Today, the broader US equity market was trading in the red. At 2:15 PM ET, the S&P 500 and the Dow were down 0.1%. The cannabis sector showed more weakness.
Cannabis Roundup: MMEN, APHA, CRON, and ACB
With today’s decline in September’s Consumer Confidence Index, the broader equity markets and the cannabis sector took a hit as well.
Cannabis Samples Didn’t Pass Tests in Nevada
The Nevada Department of Taxation announced that four cannabis products sold between May 28 and July 10 failed the secondary microbial test.
Cannabis Roundup: MMEN, ACB, WEED, and CTST
Today at 2:10 PM ET, the S&P 500 Index fell 0.3% as investors watched rising oil prices. The cannabis sector also fell today, as its ETFs traded in the red.